Treatment with Imatinib inhibits NF-kB and AP-1 activation and intracellular calcium levels InsP3 or ATP-induced in CML patients.

Authors
Publication date
1 January 2011
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio della ricerca - Università degli studi di Napoli Federico II

    redirect
    oaioai:www.iris.unina.it:11588/40...
    Last time updated on 12/11/2016